Marlborough: Boston Scientific Corporation has announced that the company has received approval from the U.S. Food and Drug ...

Boston Scientific has claimed a new approval from the FDA for its Farapulse pulsed field ablation system, expanding its use ...

Undeniably, Barchart’s screener for unusual stock options volume is an important tool for deciphering market sentiment, ...

With a market cap of $154.3 billion, Boston Scientific Corporation (BSX) is a global developer, manufacturer, and marketer of ...

Boston Scientific (NYSE: BSX) announced that the FDA approved an expansion to the label of its Farapulse pulsed field ...

Boston Scientific announces conference call discussing second quarter 2025 results. Boston Scientific Corporation (NYSE: BSX) will webcast its conference call discussing financial results and ...

Boston Scientific has become a big deal-maker under chief executive Mike Mahoney. – Topher Cox. For over a decade before the Guidant bidding war, Boston Scientific had been an aggressive deal-maker.

Boston Scientific’s Relievant Medsystems used at least 80 unclaimed bodies for training, including that of a murdered 21-year-old woman whose family was fighting to bring her home. The company ...

Boston Scientific agreed to pay Johnson & Johnson $600 million in connection with Johnson & Johnson’s botched acquisition of Guidant, a medical device company, in 2004.

Boston Scientific endured another ordeal for much of the 2000s, over surgical mesh products used for pelvic repair in women. The company, along with several others, ...